Transplantation, AutologousPeripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationMultiple MyelomaTransplantation, HomologousCombined Modality TherapyTransplantation ConditioningMelphalanHematopoietic Stem Cell MobilizationCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorLymphoma, Non-HodgkinHematologic NeoplasmsGraft vs Host DiseaseAntigens, CD34LeukapheresisBone Marrow PurgingBusulfanCarmustineStem Cell TransplantationBone MarrowTreatment OutcomeEtoposideBlood Component RemovalRemission InductionWhole-Body IrradiationGraft SurvivalHematopoietic Stem CellsRecurrenceThiotepaMyeloablative AgonistsHodgkin DiseaseCytarabineAntineoplastic Agents, AlkylatingBone Marrow CellsVincristineSalvage TherapyHematopoiesisDisease-Free SurvivalTransplantation ChimeraSurvival AnalysisLeukemia, Myeloid, AcuteSurvival RateLeukemiaTissue DonorsIfosfamideTime FactorsRetrospective StudiesCytophagocytosisDoxorubicinStem CellsNeoplasmsAmyloidosisCord Blood Stem Cell TransplantationHistocompatibilityPrednisoneLymphomaHistocompatibility TestingPlatelet CountFollow-Up StudiesTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic AgentsImmunosuppressive AgentsAnemia, AplasticBlood Cell CountCarboplatinInfectionDexamethasoneBone Marrow DiseasesLiver TransplantationProspective StudiesRecombinant ProteinsColony-Forming Units AssayPrognosisLymphoma, T-CellMyelodysplastic SyndromesLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL PositivePOEMS SyndromePodophyllotoxinFatal OutcomeT-LymphocytesHematologic DiseasesCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectVidarabineImmunosuppressionAcute DiseaseBlood CellsCyclosporineFeasibility StudiesLymphocyte DepletionImmunophenotypingActuarial AnalysisCell SeparationBreast Neoplasms